utorak, 22. siječnja 2019.

A new year is the perfect time for a fresh start!

It's your day to save on many Medtronic essentials
This content is from our sponsor.
The sponsor has sole editorial control.
Diabetes does not hold Rachel back from enjoying life and being fully
present with whomever she is with. Every day is a new beginning, so
treat it that way. What is your 2019 New Year's resolution?
EXPLORE RACHEL'S STORY Advertisement
YOUR YEAR ROUND ROUTINE STARTS HERE
An easy breakdown for year-round
diabetes care. Set your routine early and
before you know it you'll be a pro.
LEARN MORE Advertisement
10 TIPS TO A BETTER NIGHT'S SLEEP
We all know that good sleeping habits can make a huge
difference in your life. Check out these 10 tips to improve your
sleeping habits.
READ MORE   EXPLORE SLEEP ACCESSORIES
Notice of Privacy Practices | Privacy Policy | Safety Information
1 dQ&A. (2017) dQ&A Patient Panel, Q4 2016, Summary Report.
IMPORTANT SAFETY INFORMATION: MINIMED™ 670G SYSTEM
The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian™ Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the "Always" send mode.
WARNING: Medtronic performed an evaluation of the MiniMed™ 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library
©2018 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Ascensia, the Ascensia Diabetes Care logo, and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.

940M20132-011 08JAN2018
Verywell
Know More. Feel Better.
You are receiving this newsletter because you subscribed to a Verywell newsletter. If you wish to
unsubscribe, please click here.
1500 Broadway, 6th Floor, New York, NY, 10036
© 2019 Verywell.com - All rights reserved. Privacy Policy.
Advertisement Advertisement

Nema komentara:

Objavi komentar